The effects of aminoguanidine on primary and recurrent ocular herpes simplex virus infection

Hobbs, 1999, Inhibition of nitric oxide synthase as a potential therapeutic target, Ann. Rev. Pharmacol. Toxicol., 39, 191, 10.1146/annurev.pharmtox.39.1.191 Reiss, 1998, Does nitric oxide play a critical role in viral infections?, J. Virol., 72, 4547, 10.1128/JVI.72.6.4547-4551.1998 Adler, 1997, Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2), J. Exp. Med., 185, 1533, 10.1084/jem.185.9.1533 Benencia, 1999, Nitric oxide and macrophage antiviral extrinsic activity, Immunology, 98, 363, 10.1046/j.1365-2567.1999.00864.x Benencia, 2001, Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in BALB/c mice, Invest. Ophthalmol. Vis. Sci., 42, 1277 Benencia, 2003, Nitric oxide and HSV vaginal infection in BALB/c mice, Virology, 309, 75, 10.1016/S0042-6822(02)00057-0 Fujii, 1999, Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats, Virology, 256, 203, 10.1006/viro.1999.9610 Gamba, 2004, Nitric oxide and HSV vaginal infection in BALB/c mice, J. Med. Virol., 73, 313, 10.1002/jmv.20093 Karupiah, 1993, Inhibition of viral replication by interferon-γ-induced nitric oxide synthase, Science, 261, 1445, 10.1126/science.7690156 Tucker, 1996, Inhibition of nitric oxide synthesis increases mortality in sindbis virus encephalitis, J. Virol., 70, 3972, 10.1128/JVI.70.6.3972-3977.1996 J.S. Pepose, D.A. Leib, P.M. Stuart, E.L. Easty, Herpes simplex virus: anterior segment of the eye, in: J. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.), Ocular Infection and Immunity, Mosby, St. Louis, pp. 905–932. MacLean, 1998, Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses, J. Gen. Virol., 79, 825, 10.1099/0022-1317-79-4-825 Kodukula, 1999, Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system, J. Immunol., 162, 2895, 10.4049/jimmunol.162.5.2895 Laycock, 1991, Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet b radiation, Invest. Ophthalmol. Vis. Sci., 32, 2741 Keadle, 1997, Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice, J. Inf. Dis., 176, 331, 10.1086/514049 Cross, 1994, Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice, J. Clin. Invest., 93, 2684, 10.1172/JCI117282 Akaike, 2000, Nitric oxide and virus infection, Immunology, 101, 300, 10.1046/j.1365-2567.2000.00142.x Colasanti, 1999, S-Nitrosylation of viral proteins: molecular basis for antiviral effect of nitric oxide, IUBMB life, 48, 25, 10.1080/713803459 Croen, 1993, Evidence for an antiviral effect of nitric oxide, J. Clin. Invest., 91, 2446, 10.1172/JCI116479 Lipton, 1993, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds, Nature (London), 364, 626, 10.1038/364626a0 Dawson, 1991, Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues, Proc. Natl. Acad. Sci. USA, 88, 7797, 10.1073/pnas.88.17.7797 Nilsson, 1999, Biological effects of aminoguanidine: an update, Inflamm. Res., 48, 509, 10.1007/s000110050495 Foster, 1986, Genetic Studies on murine susceptibility to herpes simplex keratitis, Immunopathology, 40, 313, 10.1016/0090-1229(86)90036-X Kastrukoff, 1986, Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system of mice, J. Gen. Virol., 67, 613, 10.1099/0022-1317-67-4-613 Lopez, 1981, Resistance to herpes simplex virus-type 1 (HSV-1), Curr. Top. Microbiol. Immunol., 92, 15 Harbour, 1981, Acute and recurrent herpes simplex in several strains of mice, J. Gen. Virol., 55, 31, 10.1099/0022-1317-55-1-31 Huang, 2003, Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray, Invest. Ophthalmol. Vis. Sci., 44, 3409, 10.1167/iovs.03-0162 Stenger, 1994, Tissue expression of inducible nitric oxide synthase is closely associated with resistance to leishmania major, J. Exp. Med., 180, 783, 10.1084/jem.180.3.783 Yoshida, 1995, Dissection of strain differences in acquired protective immunity against Mycobacterium bovis Calmette-Guerin Bacillus (BCG) macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase, J. Immunol., 155, 2057, 10.4049/jimmunol.155.4.2057 Akaike, 1996, Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals, Proc. Natl. Acad. Sci. USA, 93, 2448, 10.1073/pnas.93.6.2448 Kreil, 1996, Nitric oxide and viral infection: no antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo, Virology, 219, 304, 10.1006/viro.1996.0252 Streilein, 1997, Immunity causing blindness: five different paths to herpes stromal keratitis, Immunol. Today, 18, 443, 10.1016/S0167-5699(97)01114-6 Keadle, 2002, CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice, Microbial. Pathol., 32, 255, 10.1006/mpat.2002.0506